Apixaban for Cryptogenic Stroke With Atrial Cardiopathy Apixaban for Cryptogenic Stroke With Atrial Cardiopathy

In patients with cryptogenic stroke and evidence of atrial cardiopathy without atrial fibrillation, apixaban did not reduce recurrent stroke vs aspirin in the ARCADIA trial.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Cardiology Source Type: news